USA-based biotech IMMvention Therapeutix yesterday revealed it has entered into a strategic collaboration and license ...

Just because Wall Street likes a stock doesn't mean it's a great pick. However, it's not a bad idea to at least consider how ...

The stock price of the two most prominent players in the diabetes and obesity care market, Novo Nordisk NVO and Eli Lilly LLY ...

Health Canada is recalling compounded drugs containing semaglutide, which is a key component in popular medications like Ozempic and Wegovy.

Driven by Biopharmaceutical Innovations and Gene Therapies, the market Booms Amidst Growing Incidence of Hemophilia and Von Willebrand Disease ...

Darzalex, which treats multiple myeloma, has become the first Johnson & Johnson drug to ever top $3 billion in quarterly ...

The city of Greensboro has joined a national litigation campaign suing the nation's three largest pharmacy benefit managers and three largest insulin manufacturers with the goal of lowering insulin pr ...

As the industry gathers at Paris Fashion Week, bosses are eyeing a revival in demand across the Atlantic to kick-start a ...

A major new study has revealed a long list of benefits and some little-known risks of Ozempic and other GLP-1 medications.

Events and conferences continue to connect Vancouver-based researchers with investors, as governments move money into ...

Dr. George Carroll runs BeSlimMD, a private weight loss clinic in Maitland. He has been helping patients lose weight for more than 40 years, but says when so called GLP-1 drugs made from semaglutide ...

Bankers are betting the Trump administration heralds a new wave of megamergers that wasn’t feasible under former president’s ...